Fatal Case of Pulmonary Invasive Aspergillus after Heart Transplant with a Rapidly Progressive Course

B Shakerian1, N Razavi2, M H Mandegar1

  • 1Department of Cardiovascular Surgery, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Invasive fungal infections are rare but deadly in heart transplant patients. One case showed rapid death from invasive pulmonary aspergillosis within 10 hours, despite prompt treatment.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Transplantation

Background:

  • Invasive fungal infections (IFIs) pose a significant threat to heart transplant recipients, despite their lower incidence compared to bacterial infections.
  • These infections can lead to severe morbidity and mortality, ranging from asymptomatic colonization to life-threatening disseminated disease.

Observation:

  • This report details a cardiac transplant recipient who rapidly succumbed to invasive pulmonary aspergillosis.
  • The patient experienced a swift decline, with death occurring just 10 hours after diagnosis.

Findings:

  • The rapid progression of invasive pulmonary aspergillosis in this case highlights its aggressive nature.
  • Despite early diagnosis and aggressive therapeutic interventions, the outcome was rapidly fatal, contrasting with previous reports where survival was measured in days.

Implications:

  • This case underscores the critical need for heightened vigilance and rapid diagnostic/treatment protocols for IFIs in heart transplant recipients.
  • The extreme rapidity of disease progression in this instance may necessitate re-evaluation of current treatment paradigms and early warning systems for high-risk patients.

Related Concept Videos

Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
958
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
622